Month: June 2017
-
How a Virtual Assistant Can Help Your Business to Grow
Virtual assistants can play an important role. They keep the costs lower, as well as helping your business to be flexible.
-
Start-Up to Offer Neuro Disorder Speech Analytics App
A start-up enterprise in Germany is commercializing a software app to detect early signs of cognitive decline, found in dementia and other neurodegenerative disorders.
-
Understanding What Works: Why It’s Beneficial To Get Inside The Mind Of The Consumer
When you’re trying to establish a successful business, there are few things that will benefit you more than understanding what consumers want and how they think.
-
Nanoparticles Built to Detect, Measure Peanut Allergy
A chemical engineering team developed a system with nanoscale particles to better detect and diagnose the severity of peanut allergies.
-
Noninvasive Prenatal Testing is a Safe Way to Screen for Genetic Abnormalities
Noninvasive prenatal testing is a way for parents to screen their unborn child for a variety of chromosomal anomalies.
-
Preclinical Data Show Promise for Diabetic Eye Drug
Early evidence shows a drug designed as eye drops to treat diabetic macular edema, an eye disease in people with diabetes, permeates the entire eye, including the retina.
-
Immune Disease Start-Up Raises $28M in Early Funds
A new company founded to develop treatments for diseases caused by problems with the immune system is raising $28.4 million in its first round of financing.
-
Algorithm Quickly Customizes Walking Exoskeleton
Researchers at Carnegie Mellon University in Pittsburgh wrote and tested an algorithm for exoskeletons that customize the devices to a person’s walking pattern in about an hour.
-
Long-Acting Drug Blocks Opioid Effects, Withdrawal
Findings from a clinical trial show a formulation of the drug buprenorphine given once a week blocks effects of subsequent opioid exposure and withdrawal symptoms.
-
Computer-Designed Antibodies Target Alzheimer’s Proteins
Researchers in Europe designed antibodies, like those in the immune system, to attack protein deposits in the brain associated with Alzheimer’s disease.